Content about BioSante Pharmaceuticals

April 13, 2011
FDA accepts regulatory application for Bio-T-Gel

The Food and Drug Administration has accepted a regulatory approval application for a topical treatment for low testosterone made by Teva Pharmaceuticals and BioSante Pharmaceuticals, BioSante said Wednesday.

May 2, 2010
BioSante to re-initiate prostate cancer vaccine program

Drug maker BioSante Pharmaceuticals has restarted a development program for a prostate cancer vaccine, the...

© 2013 Drug Store News. All Rights Reserved.